Clarity Pharmaceuticals Ltd (ASX:CU6)
Australia · Delayed Price · Currency is AUD 3.760
-0.005 (-0.13%)
Sep 29, 2025, 1:41 PM AEST
Clarity Pharmaceuticals Market Cap
Clarity Pharmaceuticals has a market cap or net worth of 1.40 billion as of September 26, 2025. Its market cap has decreased by -40.79% in one year.
Market Cap
1.40B
Enterprise Value
1.31B
Revenue
9.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.76
Market Cap Chart
Since August 25, 2021, Clarity Pharmaceuticals's market cap has increased from 384.20M to 1.40B, an increase of 264.00%. That is a compound annual growth rate of 37.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 1.40B | 4.54% |
| Dec 31, 2024 | 1.34B | 168.49% |
| Dec 29, 2023 | 498.26M | 93.82% |
| Dec 30, 2022 | 257.07M | 35.63% |
| Dec 31, 2021 | 189.54M | -50.67% |
| Aug 25, 2021 | 384.20M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 93.96B |
| Pro Medicus | 31.54B |
| Cochlear | 18.31B |
| Sonic Healthcare | 10.45B |
| Ramsay Health Care | 7.31B |
| Telix Pharmaceuticals | 5.03B |
| Ansell | 4.57B |
| Mesoblast | 3.07B |